Dr. Kagan discusses the judges’ reactions to the argument and speculates on a possible outcome in the Myriad Genetics case, in an IP Law360 article titled “Myriad Pushes for Isolated DNA Patents in Fed. Circ.”
Please click here to read the article.
Posted: June 4, 2011
